Drug Shortage Report for DICLOFENAC
Report ID | 128917 |
Drug Identification Number | 02475065 |
Brand name | DICLOFENAC |
Common or Proper name | Diclofenac Sodium Ophthalmic Solution |
Company Name | PHARMA STULLN INC. |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | Diclofenac 0.1% Box 50xUD 0.3ml (PF) |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-11-26 |
Estimated end date | 2020-12-22 |
Actual end date | 2020-12-31 |
Shortage status | Resolved |
Updated date | 2021-01-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6500 TRANS CANADA HIGHWAY, SUITE 400 POINTE-CLAIRE, QUEBEC CANADA H9R 0A5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-26 | English | Compare |
v2 | 2020-11-26 | French | Compare |
v3 | 2020-11-27 | English | Compare |
v4 | 2021-01-02 | English | Compare |
v5 | 2021-01-02 | French | Compare |
Showing 1 to 5 of 5